Filing Details
- Accession Number:
- 0001144204-16-088278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-15 17:57:46
- Reporting Period:
- 2016-03-11
- Filing Date:
- 2016-03-15
- Accepted Time:
- 2016-03-15 17:57:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472091 | Edge Therapeutics Inc. | EDGE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1245624 | James Healy | C/O Sofinnova 000 Sand Hill Road, Bldng 4, Suite 250 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-11 | 541,343 | $7.30 | 2,852,711 | No | 4 | P | Indirect | By Fund |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Fund |
Footnotes
- Consists of 2,852,711 shares of common stock owned of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). The Reporting Person is a managing member of Sofinnova Management IX, L.L.C., the general partner of SVP IX, and as such, may be deemed to share voting and investment power with respect to such shares. The Reporting Person disclaims beneficial ownership with regard to such shares, except to the extent of his proportionate pecuniary interest therein.
Billionaire Hedge Funds
